Latest filing published 26 Sept 2022 for Nautilus Biotechnology, Inc., €62k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gwen E. Weld has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Isilon Systems, Inc. and Nautilus Biotechnology, Inc. The record holds 10 filings, for trades running from 9 February 2010 to 23 September 2022.
Market trades split into 1 purchase (€62k) and 6 sales (€557k). Taken together, the sales exceed the purchases by €495k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant. Since January 2022: 1 purchase and no sales on the market.
On 26 September 2022 came the latest disclosure, an open-market purchase for €62k in Nautilus Biotechnology, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations